Pneumocystis carinii is an obligate parasite of mammalian lungs, attaching to but not invading the alveolar epithelium. The alveolar air spaces are rich in phospholipids, which are secreted by steroid-responsive alveolar type II epithelial cells. P. carinii isolated from rat lungs was found to contain the expected structural phospholipids as well as a large amount of firmly attached disaturated phosphatidylcholine, the characteristic phospholipid of alveolar surfactant. In vitro, P. carinii cells synthesized phospholipids from simple radiolabeled precursors; disaturated phosphatidylcholine was not formed. However, washed P. carinii cells avidly adsorbed radiolabeled rat surfactant, a process that appeared to be saturable, not dependent on viability of the organisms, and abolished by incubation at 4°C. The surfactant was neither harmful nor beneficial to in vitro survival of the organisms. With the exception of high concentrations of arachidonic acid, fatty acids found in rat alveolar lining material were also not toxic. In addition, cultures consisting primarily of rat type II alveolar epithelial cells were toxic to P. carinii when the organisms were added to monolayers of type II cells at .10:1 multiplicity. At higher multiplicities, the parasite survived (but did not increase in numbers), and the type II cells deteriorated. The mechanism for this effect has not been determined.
Although Pneumocystis carinii has become a pathogen of increasing importance due to the recent spread of the acquired immunodeficiency syndrome, it is still a poorly understood parasite. It is an obligate parasite that tightly adheres to but does not invade type I alveolar epithelial cells (15) . Whereas infection with P. carinii appears to be common in humans and other mammals, disease due to P. carinii is seen only in the setting of profound immunodeficiency or chronic administration of high doses of glucocorticoids.
Normal alveoli are lined with alveolar surfactant, a phospholipid containing a large proportion of disaturated phosphatidylcholine (26, 30) . Alveolar surfactant synthesis and release by alveolar type II epithelial cells is one of many nonimmunological biochemical processes that is responsive to glucocorticoid administration (7, 8, 24, 26, 30) . The steroid sensitivity of surfactant production provides the rationale for the use of glucocorticoids in the prevention of neonatal respiratory distress syndrome (14, 26) . In vivo, although adherent to alveolar epithelial cells, P. carinii cells appear to be included within the layer of alveolar surfactant which covers alveolar epithelial cells (15 (11, 29) . Several solvent systems were used to differentiate among the major phospholipids in P. carinii preparations by using TLC on silica gel or silicic acid (6) . The (6) . The fraction of the phosphatidylcholine that was disaturated (the major component of alveolar surfactant and a minor component of cellular lecithin) was determined by two-dimensional TLC in solvent CM with osmication of the material after migration in the first dimension (17) . TLC plates were stained with iodine vapor and molybdenum blue to identify lipids and phospholipids in particular (11, 29) . Quantitation of components was performed by determination of phosphorus in spots scraped from TLC plates by the method of Rouser et al. (27) .
In other experiments, the ability of P. carinii to utilize exogenous phospholipids and precursors was examined. (16, 18, 25) . Additional confirmation of type II activity was sought by determining that [3H]choline was incorporated into disaturated phosphatidylcholine. P. carinii cells (105 to 108 per flask) were added to the monolayers, and viability after overnight incubation was assessed by phasecontrast microscopy and fluorescent microscopic determinations of acridine orange uptake (20) . To allow comparison with their behavior on other cell types, P. carinii cells were also inoculated onto monolayers of lavaged macrophages, which can kill the organism (31), and of A549 lung cells, which can support limited replication (3, 4).
RESULTS
As determined by TLC, phospholipids of P. carinii were comparable to those expected in eucaryotic cells in general (Table 1) . However, a large amount of disaturated phosphatidylcholine remained associated with the organisms despite extensive rinsing. In these experiments (n = 5), 25 + 5% of the phospholipid isolated from P. carinii migrated on TLC after treatment with osmium tetroxide as disaturated phosphatidylcholine. This phospholipid, which is the pri- test these possibilities, the ability of P. carinii to adsorb additional alveolar surfactant and the capacity of the organisms to synthesize phospholipids from radiolabeled precursors were evaluated.
Although phosphatidylcholine extracted from P. carinii obtained from rat lungs was composed of almost equal proportion of saturated and partially unsaturated phosphatidylcholine (Table 1 The apparent avidity of P. carinii for alveolar surfactant and the almost total restriction of the organisms to alveolar air spaces raised the possibility that alveolar type II cells would support in vitro growth of P. carinii. That, however, proved not to be the case. P. carinii cells did not grow on type II pneumocyte cultures (Fig. 2) . Instead, the organisms disappeared from the cultures. The toxicity of these cultures for P. carinii was such that dead organisms could not be identified in the medium; in all situations in which there was loss of P. carinii, organisms could not be found in centrifuged samples of the medium. By light microscopy, there was no evidence of phagocytosis of the organisms by adherent cells. When high concentrations of P. carinii were coincubated with type II pneumocyte cultures, the outcome was more variable. At the highest concentrations tested, deterioration of the type II cell monolayers was apparent with, as determined by light microscopic examination and enumeration of acridine orange-stained preparations, neither death nor growth of P. carinii. In other experiments, medium conditioned by incubation with type II alveolar epithelial cells was found not to cause lysis of P. carinii or to diminish viability as determined by [14C]glucose utilization or acridine orange uptake, although agglutination of the organisms into long strands was observed in some experiments. The effect appeared to require some participation of the P. carinii cells, since P. carinii cells killed by incubation at 56°C for 30 min were not eliminated from medium and, at high inocula, were not toxic to type II cells.
These findings differed from experiments in which P. carinii cells were added to monolayers of either rat alveolar macrophages or A549 cells. Although rat alveolar macrophages can ingest and degrade P. carinii in vitro (31), they do not efficiently extract P. carinii cells from overlying medium; when 1 x 106 to 5 x 106 P. carinii cells were added to monolayers of approximately 5 x 105 macrophages, the numbers remaining uningested and viable after 24 h by acridine orange staining were 80 + 9% of starting values (n = 3). On the other hand, A549 cells, which can support limited growth of P. carinii (4), in my hands, resulted in no change in numbers of P. carinii (95 + 17%) present and viable in the medium at 24 h, when inoculating conditions were as described above. In two additional experiments, the addition of 108 P. carinii cells to A549 cells resulted in the destruction of the A549 cell monolayer, again without apparent effect on the numbers of P. carinii cells.
DISCUSSION
These data further expand understanding of the biochemical capabilities of P. carinii and provide additional information that may be relevant to understanding the mechanisms involved in host defenses against the parasite. Available data suggest that P. carinii is capable of utilizing simple substrates in energy production and synthesis of proteins (23) .
Metabolism of [14C] glucose to 14CO2 appears to be a major route of energy production (23) , although the steps in the pathway remain obscure. The parasite resists destruction by antibody with or without complement (20) but is ingested and killed by alveolar macrophages (31), a process that is enhanced by presence of specific antiserum (19) . P. carinii is susceptible to killing by reactive oxygen derivatives and by an acidic environment (21) , both of which may contribute to the lethal activity of normal macrophages against the parasite as well as to the apparent elimination of the parasite during the course of acute Pseudomonas aeruginosa pneumonia (22) .
In the alveoli, P. carinii grows as a surface parasite on the type I (or gas-transporting) cells, which have not yet been cultured in vitro, intimately associated with and perhaps totally enveloped by alveolar surfactant (15) . Type II alveolar epithelial cells have at least two major roles in the lung. The produce alveolar surfactant and, after lung injury, dedifferentiate, replicate, migrate, and differentiate into type I epithelial cells (28) . Because P. carinii grows in an environment rich in phospholipids, the current work concerning the interactions between P. carinii and lipids likely to be present in the alveolar was undertaken.
The data indicate that P. carinii, when obtained from the lungs of rats with steroid induced infections, is intimately associated with surfactant phospholipids and is capable of further adsorption of surfactant. Whether this is nonspecific adsorption or is mediated by specific binding of phospholipid or of surfactant apoprotein (26, 30) cannot be determined at this time. Similarly, the means for determining in an in vitro system the role of this absorbed surfactant is protecting the P. carinii from recognition or attack by host inflammatory cells are not evident. Other parasites appear to evade host defense effectors by acquisition of host molecules (1). Although it is plausible that surfactant serves that function for carinii, direct proof cannot be obtained at the present time. However, it is clear from these data that the disaturated phosphatidylcholine used as a marker for surfactant was not made by P. carinii, since phospholipids synthesized by P. carinii contain little disaturated lecithin. With the relatively crude methodology of TLC and focusing specifically on phospholipids, no other phospholipids appear to be present in unusual amounts. The parasite does not appear to be dependent upon the host for production of structural phospholipids from simple precursors and appears capable of synthesizing a variety of such phospholipids.
Alveolar surfactant appears to function to stabilize alveoli against collapse; deficiency of surfactant is associated with respiratory insufficiency, most striking in the respiratory distress syndrome of newborns. It is possible that the adsorption of surfactant by P. carinii contributes to the hypoxia which is characteristic of the P. carinii pneumonia. Rats with steroid-induced pneumocystosis have been found to have a decreased amount of surfactant in cell-free bronchoalveolar lavage fluid at a stage of the disease which was less advanced than that of the animals used in these experiments (12) . In addition, Kernbaum et al. (12) found increased levels of phospholipase activity in the lavage fluid of rats with pneumocystosis. Thus, it appears that the amount of surfactant may be reduced by adsorption and enzymatic degradation during pneumocystosis, and it is reasonable to assume that this deficiency of surface-active material contributes to the profound hypoxemia in the disease.
Since surfactant was rapidly adsorbed to P. carinii and the organisms are intimately associated with it in vivo, it seemed possible that it would be beneficial to in vitro growth of the organisms. If this were the case, it would support the suggestion that induction of pneumocystosis by glucocorticoids was partially mediated by nonimmunological biochemical alterations induced by the drugs. However, no improvement in growth of P. carinii on A549 cells or in vitro survival in tissue culture medium resulted from the addition of surfactant to the medium or by pretreating P. carinii cells with surfactant before incubation. Type II cells, rather than serving as substrates for growth (as I had hoped) or at least not affecting in vitro survival of P. carinii (as I had expected), caused elimination of the parasites from culture when the inoculum of the parasite was low. Attempts to delineate the mechanisms involved have not been successful. The effect requires that viable P. carinii cells be coincubated with viable monolayers containing predominantly type II cells. Macrophage monolayers did not reproduce the phenomenon; although phagocytosis and intracellular killing of P. carinii did occur, elimination of the parasite from the medium within 24 h was not seen. Dead P. carinii cells did not disappear from the medium, and medium conditioned by prior culture with type II cells was not harmful to P. carinii. Although the analogy may be tenuous, the effect appears superficially similar to that documented for lysis of bacteria by penicillin, in which autolytic enzymes are activated by a low-molecular-weight compound (10) . A variety of fatty acids known to be present in rat alveolar lining material (2) and which may be secreted by type II epithelial cells were tested; with the exception of arachidonic acid at concentrations that appear to be too high to be biologically relevant, none of the fatty acids which are lethal for pneumococci was detrimental to P. carinii survival. It remains possible that the interaction of P. carinii with alveolar lipids is more complex, requiring the presence of both lipids and lipases, as may be the case with Giardia lamblia (9) .
